AGM Date: 30 Sep 2021
AGM 30/09/2021 In the just concluded Meeting of Directors of the Company, the Board has considered and approved the matters pertains to conducting of 36th AGM and Notice Agenda items. This intimation is also uploaded in the Company website: www.gennexlab.com. We request you to take note of the above information on record and acknowledge the receipt of the same. Dear Sir/Maam Pursuant to the provisions of Regulation SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time (Listing Regulations) please find enclosed herewith the proceedings of the 36th electronic Annual General Meeting (eAGM) of the Company held on Thursday September 30 2021 at 12:30 P.M. through Video Conferencing/ Other Audio Visual Means. This intimation is also uploaded in the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same. Thanking you Yours Truly For Gennex Laboratories Limited Sd/- Rajesh Vankadara Company Secretary & Compliance Officer Membership #A44949 (As Per BSE Announcement Dated on 9/30/2021 2:06:22 AM) In compliance to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (Listing Regulations), we wish to inform you that the Shareholders of the Company by way of Special Resolutions passed through eVoting on Thursday, September 30, 2021, have by requisite majority approved the following resolutions: 1. Adoption of Object clause of MoA as per provisions of Companies Act, 2013 and Increase of Authorized Share Capital; 2. Adoption of a new set of Articles of Association ('AOA') of the Company containing regulations in conformity with the Companies Act, 2013; Further, the brief details of the alteration in the MOA and the New AOA as required under Regulation 30 of SEBI (LODR) Regulations, 2015 are annexed herewith marked as Annexure - I and Annexure - II respectively. (As Per BSE announcement Dated on 01.10.2021)
AGM Date: 30 Sep 2022
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement), Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2022 to September 30, 2022 (both days inclusive) for the purpose of the 37th Annual General Meeting ('AGM') to be held on Friday, September 30, 2022, for the Financial Year 2021-22. This intimation is also uploaded in the Company website: www.gennexlab.com. We request you to take note of the above information on record and acknowledge the receipt of the same. Pursuant to Reg.30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 37th Annual General Meeting (AGM) of the Company held on Friday, September 30, 2022 through video conferencing ('VC') / other audio visual means ('OAVM''). The meeting was held in compliance with issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (SEBI) and other applicable provisions of the Companies Act, 2013 read with rules made thereunder. The Meeting commenced at 12:30 Hrs and concluded at 13:20 Hrs. (As Per BSE Announcement dated on 30.09.2022)
AGM Date: 30 Sep 2023
we hereby submits the 38th Annual Report of Gennex Laboratories Limited ('the Company') for the Financial Year ended March 31, 2023, along with the Notice of the 38th Annual General Meeting to be held on September 30, 2023, have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com, and are also available for inspection at the Registered Office of the Company during office hours Further, inform you that U/Sec. 108 of the Companies Act, 2013 and the Rules, 2014, as amended, and Reg.44 of SEBI (LODR) Regulations, 2015, the Company is pleased to provide its member''s facility to exercise their right to vote on resolutions proposed to be passed in the AGM, by electronic means. The details as per the provisions of the Companies Act, 2013 are given in the attached Notice. This intimation is also uploaded on the Company website: www.gennexlab.com Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2023 to September 30, 2023 (both days inclusive) for the purpose of the 38th Annual General Meeting (AGM) to be held on Saturday, September 30, 2023, for the Financial year 2022-23. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt. In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors''/ Board Report for the Financial Year March 31, 2023; 2. The 38th Annual General Meeting of the Company to be held on Saturday, September 30, 2023 at 12:30 P.M.; 3. Secretarial Audit Report issued by Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata; 4. Appointment of Ms. Ekta Goswami, Practicing Company Secretary, Kolkata as Scrutinizer for the AGM; 5. Book Closure Date in connection with 38th AGM between September 23, 2023 to September 30, 2023; 6. Appointment of Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata as a Secretarial Auditor for the Financial Year 2023-24. We hereby submit that the Board Meeting had commenced at 04:30 PM and concluded at 05:00 PM. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same. (As Per BSE Announcement dated on 06.09.2023) In compliance to Regulation 44 of SEBI (LODR) 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 38th eAGM of the Company held on September 30, 2023 at 12.30 Hrs through video conferencing (''VC'')/ other audio visual means (''OAVM'') along with Scrutinizer Report. It is to inform that all resolutions set out in the Notice of the 38th eAGM were duly approved by shareholders with requisite majority. the voting results along with Scrutinizer Report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com (As Per BSE Announcement dated on 30.09.2023)
AGM Date: 30 Sep 2024
Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2024 to September 30, 2024 (both days inclusive) for the purpose of the 39th Annual General Meeting (AGM) to be held on Monday, September 30, 2024, for the financial year 2023-24. The intimation is also being uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 39th AGM of the Company held on Monday September 30, 2024 through video conferencing (VC) / other Audio Visual means (OAVM). The meeting was held in compliance with various circulars issued by MCA and SEBI and other applicable provisions of the Companies Act, 2013 read with rules made thereunder. The meeting commenced at 12.30 Hrs and concluded at 13.05 Hrs. All the requisite Statutory Registers and other requisite documents were available electronically during the AGM for inspection by the members. This intimation is also uploaded in the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same. (As per BSE Announcement dated on 30/09/2024) In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 39th AGM of the Company held on September 30, 2024 at 12.30 Hrs through Video Conferencing (VC) / Other Audio Visual Means (OAVM) along with the Consolidated Scrutinizers Report. It is inform to that all resolutions set out in the Notice of the 39th eAGM were duly approved by the shareholders with requisite majority. The voting results along with the Scrutinizers report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same. (As Per BSE Announcement dated on 01.10.2024)
AGM Date: 30 Sep 2025
The4O0th Annual General Meeting of the Company to be held on Tuesday, September 30, 2025 at 12:30 P.M.; In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 40th electroic Annual General Meeting of the Company held on September 30, 2025 at 12.30 Hrs through Video Conferencing and Other Audio Visual Means along with the Consolidated Scrutinizers Report. It is to inform that all resolutions set out in the Notice of the 40th eAGM were duly approved by shareholders with requisite majority. The vosting results along with the Scrutinizers report is also being enclosed in this letter and uploaded on the website of the Company i.e., www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same. (As per BSE Announcement dated on: 01.10.2025)
EGM Date: 30 Dec 2023
Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from 24.12.2023 to 30.12.2023 (both days inclusive) for the purpose of EGM to be held on Saturday 30.12.2023, to seek the approval of the shareholders of the Company inter alia in relation to: 1. Increase in authorised share capital from Rs. 20 Crore to 25 Crore. 2. Issuance of upto 5,00,00,000 equity shares of the Company having face value of Re.1/- each on preferential basis to specified persons. 3. Issuance of upto 1,55,00,000 share warrants of the Company to the promoters and members of the promoter group on a preferential basis. The intimation is also being uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same. Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 in furtherance to our intimation dated 20/11/2023 and 29/11/2023, we wish to inform you that Board of Directors of the Company, at its meeting held today, on 02/12/2023 has considered and approved the following: 1. To increase the authorised share capital of the Company from Rs. 20 Crore to Rs. 25 Crore and consequential alteration in Clause V of the MOA and Clause 4(i) of the AOA of the Company subject to approval of the shareholders of the Company. 2. Issuance of upto 5,00,00,000 equity shares of the Company having face value of Rs. 1/- each on preferential basis to specified persons 3. Issuance of upto 1,55,00,000 share warrants of the Company to the promoters and members of promoter group on a preferential basis 4. Calling of Extraordinary General Meeting 5. Book Closure for ensuing EGM and record date/ cut-off date for e-voting. The meeting commenced at 2:00 pm and concluded at 4:00 pm. (As Per BSE Announcement Dated on 02.12.2023) Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from 24.12.2023 to 30.12.2023 (both days inclusive) for the purpose of EGM to be held on Saturday 30.12.2023, to seek the approval of the shareholders of the Company inter alia in relation to: 1. Increase in authorised share capital from Rs. 20 Crore to 25 Crore. 2. Issuance of upto 5,00,00,000 equity shares of the Company having face value of Re.1/- each on preferential basis to specified persons. 3. Issuance of upto 1,55,00,000 share warrants of the Company to the promoters and members of the promoter group on a preferential basis. The intimation is also being uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same. (As Per BSE Announcement Dated on 04/12/2023) Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper Publication of EGM Notice and e-Voting related instructions advertisement cutting published in Business Standard and Saksham (Local) on December 08, 2023 for the Extraordinary General Meeting of the Company to be held on December 30, 2023. We request you to take the above information on record and acknowledge the receipt. (As Per BSE Announcement Dated on 09.12.2023) The EGM was held on Saturday, December 30, 2023 at !2:30 P.M. through Video Conferencing / Other Audio Visual Means. The following item of business was recommended for members'' consideration and approval: 1. To increase the authoirsed share capital of the Company from Rs.20 Crores to Rs.25 Crores and consequential alteration in Clause V of the MOA and Clause 4(i) of the AOA of the Company. 2. Issuance of upto 5,00,00,000 equity shares of the Company having face value of Re.1/- each on preferential basis to specified persons at a price of Rs.14.75 each. 3. Issuance of upto 1,55,00,000 share warrants of the Company to the promoters and members of promoter group on a preferential basis at a price of Rs.14.75 each. All the above three resolutions were put for approval by Special Resolution. Corrigendum dated December 20, 2023 to EGM Notice put for members'' ratification. The meeting concluded at 1:02 P.M. This is for your information and records. In Compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, please find herewith Voting results of the electronic Extra-ordinary General Meeting of the Company held on December 30, 2023 at 12.30 Hrs through Video Conferencing / Other Audio Visual Means along with the Consolidated Scrutinizers report. It is to inform you that all resolutions set out in the Notice of eEGM were duly approved by shareholders with requisite majority. The Voting results along with Scrutinizers Report is also uploaded on the website of the Company i.e. www.genexlab.com We request you to take the above information on record and acknowledge the receipt. (As Per BSE Announcement Dated on 30/12/2023)
